share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  Nov 30, 2023 16:31

Gainers

  • Altimmune (NASDAQ:ALT) shares increased by 45.2% to $4.59 during Thursday's after-market session. The company's market cap stands at $246.6 million.
  • NovaBay Pharmaceuticals (AMEX:NBY) stock increased by 9.89% to $0.33. The market value of their outstanding shares is at $2.1 million.
  • China Pharma Holding (AMEX:CPHI) shares rose 9.63% to $0.12. The market value of their outstanding shares is at $3.9 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock moved upwards by 9.48% to $1.08. The company's market cap stands at $4.0 million.
  • Minerva Surgical (NASDAQ:UTRS) stock increased by 8.1% to $2.0. The market value of their outstanding shares is at $17.7 million.
  • Akanda (NASDAQ:AKAN) stock increased by 7.95% to $0.53. The company's market cap stands at $2.0 million.

Losers

  • Ampio Pharmaceuticals (AMEX:AMPE) shares declined by 20.5% to $4.58 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 million.
  • Corbus Pharmaceuticals (NASDAQ:CRBP) stock declined by 9.23% to $6.0. The company's market cap stands at $26.5 million.
  • Eagle Pharmaceuticals (NASDAQ:EGRX) shares decreased by 8.55% to $5.35. The company's market cap stands at $69.4 million.
  • bioAffinity Technologies (NASDAQ:BIAF) stock declined by 8.49% to $1.51. The market value of their outstanding shares is at $14.3 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock decreased by 8.34% to $4.63. The market value of their outstanding shares is at $4.5 million.
  • LumiraDx (NASDAQ:LMDX) shares declined by 8.12% to $0.16. The company's market cap stands at $50.5 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment